Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
33.09
+1.77 (5.64%)
Oct 19, 2026, 11:47 AM EDT - Market open

Agios Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,9751,5871,8741,2451,5431,785
Market Cap Growth
-17.84%-15.30%50.56%-19.32%-13.57%-40.52%
Enterprise Value
1,042375274448607488
Last Close Price
31.3227.2232.8622.2728.0832.87

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--2.78--1.11
Forward PE
-7.847.84---
PS Ratio
19.0129.3851.3546.40108.35-
PB Ratio
1.821.331.221.541.401.38
P/TBV Ratio
1.821.331.221.541.401.38

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
9.526.937.5116.7042.61-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.040.090.080.08
Net Debt / Equity Ratio
-0.91-0.94-0.96-0.90-0.92-0.92
Net Debt / EBITDA Ratio
2.062.413.511.912.663.22
Net Debt / FCF Ratio
2.562.983.772.473.222.88
Asset Turnover
0.080.040.030.030.01-
Inventory Turnover
11.9611.4313.0821.65--
Quick Ratio
9.1410.5311.0611.4912.5417.17
Current Ratio
10.2211.4611.9012.2713.3017.79
Return on Equity (ROE)
-34.34%-30.20%57.29%-36.83%-19.38%-42.15%
Return on Assets (ROA)
-22.24%-19.93%-20.47%-22.49%-18.17%-20.65%
Return on Invested Capital (ROIC)
-108.33%-87.18%-98.60%-153.69%-100.74%-251.59%
Return on Capital Employed (ROCE)
-44.20%-38.90%-26.90%-45.00%-33.10%-27.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-22.00%-26.00%35.95%-28.29%-15.02%89.89%
FCF Yield
-19.53%-23.77%-20.89%-23.87%-20.38%-23.14%
Buyback Yield / Dilution
-0.43%-0.14%-4.02%-1.57%9.36%12.39%
SEC Filings: 10-K · 10-Q